Literature DB >> 18292107

Increase in the level of macrophage colony-stimulating factor in patients with systemic lupus erythematosus.

P T Yang, W G Xiao, L J Zhao, J Lu, L M He, H Kasai, M Ito.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18292107     DOI： 10.1136/ard.2007.076117

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Monoclonal antibody against macrophage colony-stimulating factor suppresses circulating monocytes and tissue macrophage function but does not alter cell infiltration/activation in cutaneous lesions or clinical outcomes in patients with cutaneous lupus erythematosus.

Authors:  K Masek-Hammerman; E Peeva; A Ahmad; S Menon; M Afsharvand; R Peng Qu; J B Cheng; J Syed; Y Zhan; S P O'Neil; S Pleasic-Williams; L A Cox; D Beidler
Journal:  Clin Exp Immunol       Date:  2015-11-09       Impact factor: 4.330

2.  Unravelling the pathogenesis of lupus nephritis: novel genetic study confirms decisive contribution of circulating colony-stimulating factor-1 (CSF-1).

Authors:  Thomas Rauen; Peter R Mertens
Journal:  Int Urol Nephrol       Date:  2010-03-18       Impact factor: 2.370

Review 3.  Anti-colony-stimulating factor therapies for inflammatory and autoimmune diseases.

Authors:  John A Hamilton; Andrew D Cook; Paul P Tak
Journal:  Nat Rev Drug Discov       Date:  2016-12-29       Impact factor: 84.694

4.  Colony-stimulating factor-1: a potential biomarker for lupus nephritis.

Authors:  Julia Menke; Kerstin Amann; Lorenzo Cavagna; Maria Blettner; Arndt Weinmann; Andreas Schwarting; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2014-07-10       Impact factor: 10.121

5.  Genetic variation and coronary atherosclerosis in patients with systemic lupus erythematosus.

Authors:  C P Chung; J F Solus; A Oeser; C Li; P Raggi; J R Smith; C M Stein
Journal:  Lupus       Date:  2014-04-03       Impact factor: 2.911

Review 6.  Pathogenic Inflammation and Its Therapeutic Targeting in Systemic Lupus Erythematosus.

Authors:  Timothy A Gottschalk; Evelyn Tsantikos; Margaret L Hibbs
Journal:  Front Immunol       Date:  2015-10-28       Impact factor: 7.561
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.